About CytoTronics
CytoTronics is a Healthcare company based in Boston (United States) founded in 2015 by Vince Wu. Cell-based assays for drug discovery are developed via CMOS platform. CytoTronics has raised $22.75 million across 2 funding rounds from investors including Anzu Partners and Milad Alucozai. The company has 22 employees. CytoTronics offers products and services including Pixel and Cloud-Based Software. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is CYTOTRONICS, INC. Its competitors include Kiyatec, Lucid Scientific and HistoRx; 3 of its 3 listed competitors have raised funding.
Company details
CytoTronics was founded in 2015 in Boston, United States, and operates in the biotechnology sector focused on drug discovery. Cell-based assays are enabled through a CMOS electronics platform, which measures and manipulates live cells for real-time, high-resolution electrical and electrochemical analysis. Optics-free imaging is facilitated, supporting applications in pharmaceutical research and development.
- Headquarters Boston, United States
- Employees 22
- Founders Vince Wu
- SectorsHealthcare
- Email••••••••
- Website cytotronics.com
- Social LinkedIn
- Legal Name Cytotronics, Inc
- Total Equity Funding$22.75M (USD)
in 2 rounds
- Latest Funding Round$13.5M (USD), Series A
Mar 2024
- InvestorsAnzu Partners
& 1 more
- Employee Count22
Products & Services of CytoTronics
CytoTronics offers a comprehensive portfolio of products and services, including Pixel and Cloud-Based Software.
Enables monitoring of live-cell functions for biological research applications.
Facilitates quick analysis of live-cell measurements for cellular insights.
Funding Insights of CytoTronics
CytoTronics has successfully raised a total of $22.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13.5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.75M
- Total Rounds 2
- Last Round Series A — $13.5M
- First Round $9.25M
(Apr 2022)
- Investors Count 2
All 2 funding rounds of CytoTronics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $13.5M | Series A | – | – | – |
| Apr 2022 | $9.25M | Seed | – | Anzu Partners |
2 investors in total: 1 institutional and 1 angel.
Investors in CytoTronics
CytoTronics has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Anzu Partners and Milad Alucozai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in industrial and life sciences technology companies. | anzupartners.com | Washington, Dc, United States | ||
MA Milad Alucozai | unknown_ed2bcd508a2244298 |
Investor details for CytoTronics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CytoTronics
11 people are tracked at CytoTronics (5 in leadership, 1 in board & advisors, 5 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Vince Wu | Co-Founder | Leadership |
Jeffrey Abbott | Co-Founder & CEO | Leadership |
Vince Wu (Wenxuan) | Co-founder & CTO | Leadership |
Shalaka Chitale | Head Of Biology And Data Science | Leadership |
Martin Schwalm | VP Of Engineering | Leadership |
Hongkun Park | Advisor | Board & advisors |
Brendan Powers | Principal Software Engineer | Team |
Pooja Suresh | Senior Data Scientist | Team |
Mickey Cheah | Principal ASIC Design Engineer | Team |
Ishan Nag | Associate Scientist | Team |
Keith Olson | Scientific Advisor | Team |
Complete people profiles for CytoTronics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CytoTronics
3 dated milestones of CytoTronics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded CytoTronics is founded.
- Funding First funding round of $9.2M.
- Funding Latest funding round, Series A, of $13.5M.
Competitors of CytoTronics
CytoTronics has 3 listed competitors in our database, 3 of them funded. They include Kiyatec, Lucid Scientific and HistoRx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| lucidsci.com | 2012 | Atlanta, United States | $12.73M | Real-time cell analyzers are developed for oxygen consumption monitoring. | ||
| historx.com | 2001 | Branford, United States | $13.26M | Tissue-based diagnostic solutions for research and clinical pathology markets |
Detailed competitors of CytoTronics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CytoTronics
The website of CytoTronics (cytotronics.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 29.6% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as CytoTronics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytotronics
Complete news archive for CytoTronics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CytoTronics
CytoTronics was founded in 2015 and raised its 1st funding round 7 years after it was founded.
CytoTronics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
CytoTronics is a funded company, having raised a total of $22.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $9.25M, raised on Apr 2022.
CytoTronics has 22 employees.
CytoTronics was founded in 2015 in Boston, United States, and operates in the biotechnology sector focused on drug discovery. Cell-based assays are enabled through a CMOS electronics platform, which measures and manipulates live cells for real-time, high-resolution electrical and electrochemical analysis. Optics-free imaging is facilitated, supporting applications in pharmaceutical research and development.
CytoTronics's top competitors include Kiyatec, Lucid Scientific and HistoRx.
CytoTronics offers Pixel and Cloud-Based Software.
CytoTronics has 2 investors. Key investors include Anzu Partners, and Milad Alucozai.
CytoTronics operates through Cytotronics, Inc.